GlucoTrack (GCTK)
0.61
-0.06 (8.96%)
Upcoming Events
Latest Headlines
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
May 26, 2026 8:00 AM - StreetInsider
Form 8-K Glucotrack, Inc. For: May 15
May 15, 2026 4:46 PM - SEC Filing
Form SCHEDULE 13G/A Glucotrack, Inc. Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:18 AM - SEC Filing
Form 10-Q Glucotrack, Inc. For: Mar 31
May 14, 2026 5:28 PM - SEC Filing
Form 8-K Glucotrack, Inc. For: May 14
May 14, 2026 5:27 PM - SEC Filing
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 14, 2026 5:27 PM - Globe NewsWire
Form 8-K Glucotrack, Inc. For: May 07
May 7, 2026 4:08 PM - SEC Filing
Glucotrack submits FDA application for implantable glucose monitor study
May 7, 2026 1:02 PM - StreetInsider
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
May 7, 2026 1:00 PM - StreetInsider
Form EFFECT Glucotrack, Inc.
May 1, 2026 9:20 AM - SEC Filing
Form 8-K Glucotrack, Inc. For: Apr 29
April 30, 2026 5:21 PM - SEC Filing
Form 8-K Glucotrack, Inc. For: Apr 30
April 30, 2026 10:18 AM - SEC Filing
Glucotrack publishes glucose monitoring study showing 240-day accuracy
April 30, 2026 9:02 AM - StreetInsider
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
April 30, 2026 9:00 AM - StreetInsider
Form POS AM Glucotrack, Inc.
April 29, 2026 5:29 PM - SEC Filing
Glucotrack publishes peer-reviewed study on glucose sensor longevity
April 21, 2026 8:03 AM - StreetInsider
Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
April 21, 2026 8:01 AM - Globe NewsWire
Form 8-K Glucotrack, Inc. For: Apr 14
April 14, 2026 12:15 PM - SEC Filing
GlucoTrack (GCTK) Misses Q4 EPS by 3122c
March 31, 2026 7:00 AM - StreetInsider
Form 10-K Glucotrack, Inc. For: Dec 31
March 30, 2026 5:50 PM - SEC Filing
Form 8-K Glucotrack, Inc. For: Mar 30
March 30, 2026 5:49 PM - SEC Filing
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
March 30, 2026 4:50 PM - StreetInsider
Form 8-K Glucotrack, Inc. For: Mar 27
March 27, 2026 8:25 AM - SEC Filing
Glucotrack plans FDA filing for glucose monitoring device in Q2
March 27, 2026 8:01 AM - StreetInsider
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
March 27, 2026 8:01 AM - StreetInsider
Form 8-K Glucotrack, Inc. For: Mar 12
March 13, 2026 4:06 PM - SEC Filing
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
March 10, 2026 8:01 AM - StreetInsider
Full Article List